Treatment outcome of tuberculosis patients at Gondar University Teaching Hospital, Northwest Ethiopia. A five - Year retrospective study

BMC Public Health

Volumn 9, Issue , 2009, Pages

  Tessema, Belay ^a,b   Muche, Abebe ^a   Bekele, Assegedech ^a   Reissig, Dieter ^b   Emmrich, Frank ^b,c   Sack, Ulrich ^b,c  

^a UNIVERSITY OF GONDAR   (Ethiopia)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c FRAUNHOFER INSTITUTE FOR CELL THERAPY AND IMMUNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; ETHIOPIA; EXTRAPULMONARY TUBERCULOSIS; FEMALE; HEALTH PROGRAM; HUMAN; INFANT; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; PATIENT TRANSPORT; PRACTICE GUIDELINE; PREDICTOR VARIABLE; PRESCHOOL CHILD; PUBLIC HEALTH PROBLEM; RETROSPECTIVE STUDY; SCHOOL CHILD; SEX DIFFERENCE; SHORT COURSE THERAPY; SMEAR; SPUTUM SMEAR; TEACHING HOSPITAL; TREATMENT FAILURE; TREATMENT OUTCOME; TUBERCULOSIS; TUBERCULOSIS CONTROL; URBAN POPULATION; DIABETES MELLITUS; SOCIAL SUPPORT;

DIABETES MELLITUS; HUMANS; SOCIAL SUPPORT; TREATMENT OUTCOME;

EID: 70449360341     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-9-371     Document Type: Article

References (36)

1. The world health report 2004: changing history. World Health Organisation (WHO), Geneva WHO 2004
2. Global tuberculosis control: Surveillance, planning and financing. World Health Organisation (WHO), WHO report. WHO/HTM/TB/362. Genev 2006 10.1001/archinte.163.9.1009
3. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. EL Corbett CJ Watt N Walker D Maher BG Williams MC Raviglione C Dye, Arch Intern Med 2003 163 1009 1021 10.1086/339818 12742798
4. Worldwide incidence of multidrug-resistant tuberculosis. C Dye MA Espinal CJ Watt C Mbiaga BG Williams, J Infect Dis 2002 185 1197 1202 10.1016/S0140-6736(03)14333-4 11930334
5. Tuberculosis. TR Frieden TR Sterling SS Munsiff CJ Watt C Dye, Lancet 2003 362 887 899 10.1097/00002030-200101260-00002 13678977
6. Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa. YD Mukadi D Maher A Harries, AIDS 2001 15 143 152 10.1097/00002030-200101260-00002 11216921
7. Global tuberculosis control: Surveillance, planning and financing. World Health Organisation (WHO), WHO report. WHO/HTM/TB/2008.393. Geneva 2008
8. Tuberculosis, Leprosy and TB/HIV Prevention and Control Programme Manual. Ministry of Health of Ethiopia (MOH), Addis Ababa: MOH 4 2008 10.1001/jama.279.12.943
9. Management of Tuberculosis. A guide for Low Income Countries. DA Enarson HL Rieder T Arnadottir, Paris: Int J Tuberc Lung Dis 5 2000
10. Treatment of Tuberculosis: Guidelines for National Programmes. World Health Organization, Geneva: World Health Organization, WHO/CDS/TB/2003 2003 313 1 108 10.1056/NEJM199404283301702
11. Directly observed therapy for treatment completion of pulmonary tuberculosis. Consensus statement of the public health tuberculosis guidelines panel. CP Chaulk VA Kazandjian, JAMA 1998 279 943 8 10.1001/jama.279.12.943 9544769
12. When tuberculosis treatment fails. A social behavioral account of patient adherence. E Sumartojo, Am Rev Respir Dis 1993 147 1311 20 10.1183/09031936.98. 12020505 8484650
13. The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. SE Weis PC Slocum FX Blais, N Engl J Med 1994 330 1179 84 10.1056/NEJM199404283301702 8139628
14. Global Tuberculosis Control. World Health Organization (WHO), WHO Report 2001. WHO/CDS/TB/2001 2001 287 1 181
15. Standardized tuberculosis treatment outcome monitoring in Europe. Recommendations of a Working Group of the World Health Organization (WHO) and the European Region of the International Union Against Tuberculosis and Lung Disease (IUATLD) for uniform reporting by cohort analysis of treatment outcome in tuberculosis patients. J Veen M Raviglione HL Rieder GB Migliori P Graf M Grzemska R Zalesky, Eur Respir J 1998 12 505 10 10.1016/S0929-6646(09)60212-6 9727811
16. Global Tuberculosis Control: Surveillance, Planning, Financing. WHO Report 2005 Geneva: World Health Organization. World Health Organization, WHO/HTM/TB/2005.49 2005
17. DOTS improves treatment outcomes and service coverage for tuberculosis in South Ethiopia: a retrospective trend analysis. E B Shargie B Lindtjørn, BMC Public Health 2005 5 1471 77
18. Coinfection and clinical manifestations of tuberculosis in human immunodeficiency virus- infected and -uninfected adults at a teaching hospital, northwest Ethiopia. A Kassu G Mengistu B Ayele E Diro F Mekonnen D Ketema F Moges T Mesfin A Getachew B Ergicho D Elias A Aseffa Y Wondmikun F Ota, J Microbiol Immunol Infect 2007 40 116 122 17446959
19. Treatment Outcome of Pulmonary Tuberculosis in Eastern Taiwan - Experience at a Medical Center. JJ Jyh Lee RL Wu YS Lee YC Wu CY Chiang, J Formos Med Assoc 2007 106 25 30 10.1016/S0929-6646(09)60212-6 17282967
20. Outcome of patients treated for tuberculosis in Vaud County, Switzerland. JP Zellweger P Coulon, Int J Tuberc Lung Dis 1998 2 372 377 10.1016/0277-9536(92)90271-Q 9613632
21. Working Group on Completion of Tuberculosis Treatment in Spain: Current status of treatment completion and fatality among tuberculosis patients in Spain. JA Cayla JA Caminero R Rey N Lara X Valles H Galdos-Tanguis, Int J Tuberc Lung Dis 2004 8 458 464 15141739
22. Euro TB Correspondents: Exploring the determinants of treatment success for tuberculosis cases in Europe. D Falzon Y Le Strat F Belghiti A Infuso, Int J Tuberc Lung Dis 2005 9 1224 1229 16333929
23. Tuberculosis in rural northwest Ethiopia: community perspective. H Getahun D Aragaw, Ethiop Med J 2001 39 283 291 10.1016/S0140-6736(96)90874-0 12380228
24. In search of factors responsible for non-compliance among tuberculosis patients in Wardha District, India. F Barnhoorn H Adriaanse, Social Science and Medicine 1992 34 291 306 10.1016/0962-8479(93)90053-Z 1557670
25. The true status of smear-positive pulmonary tuberculosis defaulters in Malawi. ML Kryut ND Kryut MJ Boeree AD Harries FML Salaniponi PA van Noord, Bull World Health Organ 1999 77 386 391 10361755
26. A randomized trial of the impact of counseling on treatment adherence of tuberculosis patients in Sialkot, Pakistan. R Liefooghe C Suetens H Meulemans MB Moran A De Muynck, Int J Tuberc Lung Dis 1999 3 1073 1080 10599010
27. programme changes and treatment outcomes in patients with smear-positive tuberculosis in Blantyre, Malawi. AD Harries L Nyong'Onya Mbewe FML Salaniponi, Lancet 1996 347 807 809 10.1016/S0140-6736(96)90874-0 8622340
28. The impact of supervisory activities on tuberculosis treatment. BW Jin SC Kim T Mori T Shimao, Tubercle Lung Dis 1993 74 267 272 10.1016/S0277-9536(02) 00182-X
29. A report on home visiting practices conducted in remote districts of Nepal in an NGO-run tuberculosis control programme. AJ White CM Robinson-White H Luitel, Int J Tuberc Lung Dis 1999 3 534 536 10.1378/chest.95.6.1190 10383068
30. Influence of motivation of patients and their family members on the drug collection by patients. MA Seetha N Srikantaramu KS Aneja Singh Hardan, Indian J Tuberc 1981 28 182 190 10.1016/0962-8479(93)90010-U
31. Shared vision - a health education project designed to enhance adherence to anti-tuberculosis treatment. J Dick C Lombardt, Int J Tuberc Lung Dis 1997 1 181 186 10.1016/0962-8479(94)90098-1 9441085
32. Community tuberculosis care through "TB clubs" in rural North Ethiopia. M Demissie H Getahun B Lindtjorn, Social Science and Medicine 2003 56 2009 2018 10.1016/S1473-3099(03)00609-1 12697193
33. Use of mycobacterial smears in the diagnosis of pulmonary tuberculosis in AIDS/ARC patients. NC Klein FP Duncanson TH Lenox 3rd A Pitta SC Cohen GP Wormser, Chest 1989 95 1190 1192 10.1378/chest.95.6.1190 2721251
34. Negative sputum smear results in HIV-positive patients with pulmonary tuberculosis in Lusaka, Zambia. AM Elliott K Namaambo BW Allen N Luo RJ Hayes JO Pobee KP McAdam, Tuberc Lung Dis 1993 74 191 194 10.1016/0962-8479(93)90010-U (Pubitemid 23188682)
35. The effect of human immunodeficiency virus type-1 on the infectiousness of tuberculosis. P Nunn M Mungai J Nyamwaya C Gicheha RJ Brindle DT Dunn W Githui JO Were KP McAdam, Tuberc Lung Dis 1994 75 25 32 10.1016/0962-8479(94) 90098-1 (Pubitemid 24128756)
36. Clinical diagnosis of smear-negative pulmonary tuberculosis in low-income countries: the current evidence. K Siddiqi ML Lambert J Walley, Lancet Infect Dis 2003 3 288 296 10.1016/S1473-3099(03)00609-1 12726978